TGFB1 and Abdominal obesity: The dysregulation of the renin-angiotensin system is known to produce and/or favour most of the changes, which were observed in the iMDD/HF rats, including inflammation, increased expression of TGF-β1 and related markers of fibrosis, insulin resistance and central obesity.